Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion type Assertion NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_head.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion wasGeneratedBy ECO_0000203 NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_provenance.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion wasDerivedFrom befree-20140225 NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_provenance.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion SIO_000772 22402438 NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_provenance.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion evidence source_evidence_literature NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_provenance.
- NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_assertion description "[LINE-1 hypomethylation and AIM1 hypermethylation have prognostic utility in both melanoma patients' tumors and serum.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292696.RAbuHcunvN_2vyhPf_VHp7vNItdeAXlWXY1baLWLjKICs130_provenance.